BNP and ANP Peptides as Screening Tools for Hidden Heart Dysfunction | Research

The takeaway

Brain natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) show promise as blood markers for detecting left ventricular dysfunction, even in patients without symptoms.

Screening for hidden heart disease
ANP, BNP, and cGMP compared as blood markers to detect left ventricular dysfunction before symptoms develop

What the researchers found

ANP, BNP, and cGMP were compared as screening markers for asymptomatic and symptomatic left ventricular dysfunction, with potential utility for early detection.

Why it matters

Detecting heart dysfunction before symptoms appear allows earlier treatment that can prevent heart failure progression. Simple blood markers like BNP could enable population-wide screening.

How the study worked

Cross-sectional study directly comparing plasma ANP, BNP, and cGMP levels in patients with asymptomatic versus symptomatic left ventricular dysfunction to evaluate their screening potential.

What this study cannot tell us

Cross-sectional design limits ability to determine predictive value over time. Abstract doesn't detail sensitivity/specificity values or sample sizes.

How to read the evidence

Moderate clinical evidence from a comparative biomarker study. Cross-sectional design provides diagnostic but not prognostic data.

When this study was published

Published in 1996, this is an early study in natriuretic peptide biomarker research. BNP testing has since become standard clinical practice.

The bigger picture

This study contributed to establishing BNP as a clinical biomarker for heart failure — it's now one of the most widely used blood tests in cardiology, ordered millions of times annually worldwide.

Questions still open

Which natriuretic peptide provides the best screening accuracy for asymptomatic heart dysfunction?
At what threshold levels should screening be considered positive?

Common questions

What are natriuretic peptides?

Natriuretic peptides (ANP and BNP) are hormones released by the heart when it's under stress or stretched. Higher blood levels indicate the heart is working harder than normal, making them useful markers for heart dysfunction.

Why screen for asymptomatic heart dysfunction?

Many people have weakened heart function without knowing it. Early detection allows treatment with medications like ACE inhibitors that can slow or prevent progression to full heart failure, significantly improving outcomes.

Read the original research

Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction.

Heart (British Cardiac Society), 76(2), 129-36

View on PubMed ↗

Citation

Friedl, W; Mair, J; Thomas, S; Pichler, M; Puschendorf, B. (1996). Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction.. Heart (British Cardiac Society), 76(2), 129-36.